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People of 65 years and above now comprise a greater share of the world's population than ever before, 
and this proportion will increase during the 21st century. In Spain, between 55 and 90% of the elderly 
consume a drug. This study characterizes the use of drugs by elderly through dispensing data at the 
community pharmacy.  This study was conducted at a community pharmacy in Madrid, Spain in 2011. A 
retrospective and descriptive consumption study was conducted using computerized pharmacy 
dispensing records for all pensioner patients. Anatomical Therapeutic Chemical (ATC) Classification 
code of all drugs dispensed was recorded in this database accordingly and this classification was used. 
The 10 most widely used ATC subgroups (2nd level) were determined. These most widely used ATC 
subgroups were examined using ATC-codes of the 5th level, thus mostly consumed drugs were 
estimated. A total of 40, 177 drugs were dispensed to patients with prescriptions for pensioners. Anti-
inflammatory and analgesic were by far the most widely used drugs: 37.2% of all elderly used drugs 
from this subgroup. The use of drugs from the remaining nine subgroups was considerably lower, 
ranging from 9.0% (drugs for obstructive airway diseases) to 4.5% (antineoplastic and beta blocking 
agents). Cardiac therapy and psycholeptic were used by 7.8%. Diuretic were used by 7.5% of elderly 
people, while antibacterial for systemic use and psycoanaleptic were used by 5.6%. Psychoanaleptics 
was consumed in 5.6%, mostly represented by venlafaxine and citalopram. According to the dispensing 
data, drug use in this sample is similar to that reported by other studies conducted in Spain and 
abroad. Majority of the elderly were exposed to anti-inflammatory, analgesic and drugs for obstructive 
airway diseases.  Other ATC-subgroups for treatment of cardiovascular conditions were used. This 
study demonstrates the need for involvement of pharmacists to ensure efficacy and safety in the use of 
drugs by sensitive populations such as elderly at the community setting. 
 





People of age 65 and above now comprise a greater 
share of the world's population than ever before, and this 
proportion will increase during the 21st century 
(Morchadze et al., 2009). It is projected that the elderly 
population of the world will cross the one billion mark by 
the year 2020. By that time, over 700 million old people 
will  be  living  in  developing  countries   (Hutton,   2008).   
According to Abellán and Ayala (Abellán and Ayala, 
2012), 17.4% of the Spanish population are 65 years or 
above with 98% of these persons living in their main 
family home, that is, ageing at home. The most prominent 
sociodemographic characteristics are the number of very 
elderly (43% are 75 or above), number of women (almost 









(31%), low educational level (44% have no education), 
and the predominance of pensioners (76%). The high 
number of widows/widowers and single people explains 
the significant proportion of elderly people living alone 
(20%), an aspect which mainly affects women and the 
very oldest. 
A study on drug consumption in Spain shows that 
between 55 and 90% of the elderly consume at least one 
drug (Ruíz, 2006). The average number of drugs in the 
non-institutionalized elders is between 2 and 4 drugs per 
person per day, with an average of 2.6, the proportion 
being larger in the pool of women. This consumption 
takes place over prolonged periods of time, with a high 
degree of dependence on others for taking medication 
and with high rates of self-medication. A study about drug 
prescribing and use among elderly people in Spain 
showed that drug use is highly prevalent among the 
elderly, that many medicines without any demonstrated 
benefit are being taken, and that potentially harmful drugs 
were being used by a high proportion of patients without 
medical follow-up (Mas and Laporte, 1983). Another 
study showed a high prevalence of multiple medications 
and a high percentage of elderly patients using in-
appropriate medications (35%). The same study showed 
that 77.7% of the inappropriate prescriptions originate 
from the family doctor, which is, therefore, a challenge for 
the primary care clinic (Moral et al., 2006). The results of 
the study could help to improve the medicine use among 
elderly, specifically at the community setting, from the 
knowledge of medicines more used by them. 
Furthermore, Spain has many community pharmacies, 
but there is little pharmacy practice research 
(Gastelurrutia et al., 2005). “The existence of authors 
who publish very few studies and the high insularity index 
observed in the articles may be considered as negative 
indicators for community pharmacy-based research in 
Spain” (Iglesias et al., 2007). Therefore, this study was 
conducted to characterize the use of drugs by the elderly 








A prospective and descriptive research study was conducted over 
an 11-month period (October 2010 August, 2011) in a community 
pharmacy in Madrid, Spain. The community pharmacy is a shift of 
12 h, attached to Ambulatory Health Center, which dispenses about 
4000 prescriptions each month. Like all community pharmacy in 





The study was performed with pharmacy dispensing data from the 





program in Spain developed by Unycop Pharmacy Group (Unycop, 
2012). More than 4,200 pharmacies in Spain are computerized with 
this software. Unycop Win has visual and intuitive applications 
integrated with the latest tools from Microsoft; a Menu Bar and 
"Toolbar Icons" that provide access to the entire application; and is 
adapted to the legal and administrative requirements of each region 
and fully integrated with Bot Plus, the most comprehensive 
database of pharmaceutical knowledge in Spain. This database 
comprises all prescriptions of all patients served at the community 





All drugs registered in the database and dispensed during the study 
period under code number 3 (corresponding to pensioners) were 
included in the study. Non-drug agents and accessories which 
require a medical prescription were excluded. 
 
 
Data analysis procedures 
 
The following elements from Unycop Win database were 
considered: drug name, therapeutic class, and units dispensed. The 
Anatomical Therapeutic Chemical Classification (ATC) code of all 
drugs dispensed was recorded in Unycop Win database, and 
accordingly, this classification was used in this study. In the ATC 
classification system given by World health Organization (WHO), 
the drugs are divided into different groups according to the organ or 
system on which they act and their chemical, pharmacological and 
therapeutic properties (Rønning, 2001). Drugs are classified in 
groups at five different levels. The drugs are divided into fourteen 
main groups (1st level), with two therapeutic/pharmacological 
subgroups (2nd and 3rd levels). The 4th level is a therapeutic/ 
pharmacological/chemical subgroup and the 5th level is the 
chemical substance.  
For example, the code N02BE01: the first character (N) re-
presents the main anatomical group. In this example, N = Nervous 
System. Characters two and three (02) represent the therapeutic 
subgroup. In this example, N02 = Analgesics. Character four (B) 
represents the pharmacological subgroup. In this example, N02B = 
Other analgesics and antipyretics. Character five (E) represents the 
chemical subgroup. In this example, N02BE = Anilides. Characters 
six and seven (01) represent the chemical substance. In this 
example, N02BE01 = Paracetamol (acetaminophen). 
Collected data were recorded in a database that was processed 
in Microsoft Access. The 10 most widely used active substances 
were determined using ranking the percentage. These most widely 
used ATC subgroups were examined using ATC-codes of the 5th 
level, allowing estimation of the most commonly used drugs. 
Approval from community pharmacy owner was obtained. Only 
data related to drugs sold was used. Patient data is not registered 
in the Unycop Win database, because this pharmacy does not have 
the licenses granted by the Spanish Data Protection Law for this 





Table 1 shows the ATC subgroups that were most widely 
used by elderly according to dispensing data and the 
distribution of active substances used by elderly. During 
the study period, a total of 40 177 drugs were dispensed. 
Anti-inflammatory and analgesic  drugs  were  by  far  the  
 
 








n Percentage within the subgroups
 
Percentage within the total 
M01AE01 Ibuprofen 7 203 48.1 17.9 
M01AC01 Piroxicam 3 525 23.5 8.7 
R03CC02 Salbutamol 2033 49.8 5.0 
R03AK06 Salmeterol 1856 45.5 4.6 
C08CA01 Amlodipine 1348 37.1 3.3 
C03AB03 Hydrochlorothiazide 1289 42.6 3.2 
N05CF02 Zolpidem 1233 38.8 3.0 
C01DA02  Glyceryl trinitrate 1145 36.0 2.8 
N02BA01 Acetylsalicylic acid
b 
1022 6.8 2.5 
J01CR02 Amoxicillin 995 43.9 2.4 
N02BE01 Paracetamol 906 6.0 2.2 
C01AA05 Digoxin 856 26.9 2.1 
N05BA01 Diazepam 846 26.6 2.1 
C08DA51 Verapamil 820 22.6 2.0 
J01FA10 Azithromycin 791 34.9 1.9 
C03DA01 Spironolactone 698 23.0 1.7 
N06AX16 Venlafaxine 714 31.5 1.7 
C07BB03 Atenolol 587 32.3 1.4 
L01BA01 Methotrexate 533 29.4 1.3 
N06AB04 Citalopram 460 20.3 1.1 
C07AG02 Carvedilol 361 19.9 0.8 
L01AA01 Cyclophosphamide 358 19.7 0.8 
 
a
Active substances showing an example of the two most used drugs within each of the subgroups  consumed. 
b
Concentration 




most widely used: 37.2% of all elderly used drugs from 
this subgroup. Within this subgroup, paracetamol was by 
far the most widely used analgesic followed by 
acetylsalicylic acid, ibuprofen, and piroxicam.  
The use of drugs from the remaining nine subgroups 
was considerably lower, ranging from 9.0% (drugs for 
obstructive airway diseases) to 4.5% (antineoplastic and 
beta blocking agents). Within the subgroup “drugs for 
obstructive airway diseases,” salbutamol and salmeterol 
were the most commonly used while methotrexate and 
cyclophosphamide were the most frequently prescribed 
antineoplastic drugs. Atenolol and carvedilol were the 
most commonly used beta blocking agents. 
Cardiac therapy (C01) and psycholeptics (N05) were 
used by 7.8%. Diuretics (C03) were used by 7.5% of the 
elderly, while antibacterials for systemic use and 
psychoanaleptics were used by 5.6%. The most common 
drugs dispensed within the subgroup of diuretics were 
hydrochlorothiazide and spironolactone. Digoxin and 
glyceryl trinitrate were widely used within the cardiac 
therapy subgroup. 
The ATC subgroup of calcium channel blockers was 
largely represented by the use of amlodipine and 
verapamil. The ATC subgroup of psycholeptics appeared 
to be a heterogeneous group  represented  by  drugs  like  
zolpidem and diazepam. The subgroup of 
psychoanaleptics was taken by 5.6% of the elderly and 
the most common members were venlafaxine and 
citalopram. Finally, the antibacterials for systemic use 
subgroup was used by 5.6% with the most common 





This study examined the pattern of medication use 
among the elderly in a community pharmacy in Madrid. 
The 10 most widely prescribed drugs were anti-
inflammatory drugs, analgesic drugs, and drugs for 
obstructive airway diseases. Non-steroidal anti-
inflammatory drugs (NSAIDs) were widely used within the 
analgesics+anti-inflammatory subgroup. Similar results 
were presented by Pilotto et al. (2003), who identified the 
prevalence of specific drug use in elderly outpatients and 
the relationship between NSAID use and gastrointestinal 
disturbances and therapies in elderly subjects treated by 
their general practitioner (GP). Other studies have also 
shown that NSAIDs are prescribed to a great extent in 











These results could be associated with the high 
prevalence of chronic pain in the Spanish general 
population (Català et al., 2002). General chronic pain 
prevalence in Spain was estimated at 31.4% in women 
and 14.8% in men, the most frequent causes being 
osteoarthritis/arthritis and rheumatoid arthritis, results 
epidemiologically similar to those reported for other 
European countries such as the United Kingdom, Ireland, 
Italy, Norway and Belgium (Breivik et al., 2006).  
The burdens of chronic obstructive airway diseases 
among the elderly in Europe and worldwide are 
increasing (Lundba and Gulsvik, 2003). Of the general 
Spanish population between 40 and 80 years of age, 
10.2% suffer from obstructive airway diseases (Soriano 
et al., 2010). Obstructive airway diseases in Spain 
generate approximately 10 to 12% of family doctor visits. 
Similarly, these diseases cause 35 to 40% of visits to pul-
monologists and cause 35% of permanent work disability 
(Echave-Sustaeta and Villena, 2002). This justifies the 
use of medications such as salbutamol and salmeterol 
reported in this study. 
According to studies developed by Wolf-Maier and 
Cooper, (2003), Europe should be considered a high 
prevalence hypertension region. In Germany and Finland, 
roughly 44% of the adult population can be diagnosed 
with hypertension (HT) (Wolf-Maier and Cooper, 2003).
 
Cardiovascular diseases constitute the first cause of 
death in the whole Spanish population. Both cerebro-
vascular disease and ischemic heart disease together 
account for 60% of global cardiovascular mortality 
(Redón et al., 2007). The prevalence of essential hyper-
tension in the Spanish population more than 60 years of 
age is greater than 65% (Sierra et al., 2008). Beta 
blocking agents, for example, showed a low consumption 
when compared with other subgroups in this study. 
These data are consistent with those reported in other 
studies of beta blockers consumption which also reported 
decreasing consumption with age and other pathological 
factors in the elderly (Garcia-Molla et al., 2011). At the 
same time, this result could support the hypothesis that 
beta blockers do not offer much additional benefit to the 
control of other risk factors and prevent the progression 
of target organ damage, so that they are relegated to 
specific indications (Protocolo de HTA, 2011; Che et al., 
2009).  
Likewise, cardiac therapy (ATC- group C01) showed 
considerable consumption; this result is similar to that of 
Straand and Rokstad (1999), where nitrates and digitalis 
preparations were more representative drugs. Other 
studies showed the same tendencies (Loyola et al., 2011; 
Rozenfeld, 2008).   
Our calcium channel blocker (ATC-group C08) 
consumption results are consistent with other studies 
developed at the primary care level (Mendes-Netto et al., 
2011). This result, however, conflicts with the findings of 
the PROTECT project, where  calcium  channel  blockers 
were used in 97.8% of all the cases in the outpatient 
sector (Ballarín et al., 2012). Taken together, the results 
related to drugs active on the cardiovascular system are 
consistent with the European Society of Cardiology/ 
European Society of Hypertension (ESC/ESH) guide-
lines, which recommend that thiazide diuretics should be 
considered just as suitable as β-blockers, calcium 
antagonists, angiotensin-converting-enzyme (ACE) inhibi-
tors, and angiotensin receptor blockers for the initiation 
and maintenance of antihypertensive treatment 
(Grossman and Verdecchia and Micheli, 2011). Similarly, 
psycholeptics were the drugs most used by the elderly 
according to some current studies (Tomàs, 1999; 
Ramage-Morin, 2009). 
According to the Spanish Agency for Medicines and 
Health Products, Spain is the second leading European 
Union country in antibiotic consumption after France, 
even though the use of these drugs has been reduced 
from 22.8 doses per 1,000 inhabitants/day in 1995 to 
19.8 in 2007 (Lázaro, 2008). The antibiotic consumption 
reported in this study is consistent with these findings.  
The findings related to antineoplastic agents (ATC-sub-
group L01) is consistent with cancer prevalence, because 
of the overall aging of the population and the fact that 
cancer incidence and mortality rises exponentially in the 
50 to 85 year old age groups (Nathan et al., 2006). This 
pathology in the elderly represents an increasing load for 
the community, particularly in France, Italy and Spain due 
to the ageing population in these countries (Verdecchia, 
2002). The epidemiological data could support the con-
sumption reported in this study for antineoplastic agents. 
Similarly, cyclophosphamide and methotrexate are drugs 
sold in oral dosage form at the community pharmacy. 
These drugs have been widely used as therapy to treat 
breast and prostate cancer (Colleoni et al., 2006).  
Interestingly, these results showed the use of drugs 
that, as recommended by Elliott (2006), should be 
avoided in elderly, namely, benzodiazepines and NSAID. 
According to these results, future researches will be 
necessary to address these issues, and a geriatric 
pharmaceutical care program could be viable to improve 
the coordination of pharmaceutical treatments, ensuring 
the safety of pharmacotherapy in elderly patients. 
 
 
STUDY LIMITATIONS  
 
The limitation of this study is that the consumption of 
drugs was estimated using a dispensing register. When 
using a dispensing register for investigating the con-
sumption of a drug, it must be taken into consideration 
that the register contains information on redeemed 
prescriptions and not on the actual consumption of drugs 
by the persons who redeem the prescriptions. The fact 
that there is no assurance that persons ingested the 







This limitation has also been recognized in other studies 
using dispensing data for investigating use of a drug 
(Sundell et al., 2011; González et al., 2004).
 
Another limitation is that the database is used to record 
dispensing and manage cash control, but says nothing 
about the quality of prescribing. Patient records are not 
considered in this database; therefore, it was not possible 
to estimate consumer population. Diagnostic data are not 
considered in this database; therefore, statements about 
the appropriateness of drug use cannot be made. These 
limitations are consistent with the statements of González 
et al. (2004): the pharmacy databases are designed for 
administrative control (“PharmacyManagement”) rather 





According to the dispensing data, drug use in this sample 
is similar to that reported by other studies conducted in 
Spain and abroad. Majority of the elderly were exposed 
to anti-inflammatory and analgesic drugs and drugs for 
obstructive airway diseases. Other ATC subgroups for 
the treatment of cardiovascular conditions were used. 
This study shows that the Unycop Win database is a 
valuable source for information on drug utilization, 
permitting the registration and classification of drugs 
dispensed in accordance with the ATC Classification 
System. This study shows the need for involvement of 
pharmacists to ensure effectiveness and safety for the 
use of drugs in sensitive populations such as the elderly 
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